Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study

INTRODUCTION: The novel low-dose anti-thymocyte (ATG, 5 mg/kg) plus low-dose post-transplant cyclophosphamide (PTCy, 50 mg/kg) (low-dose ATG/PTCy)-based regimen had promising activity for prevention of graft-versus-host disease (GVHD) in haploidentical-peripheral blood stem cell transplantation (hap...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xingying, Yang, Jun, Cai, Yu, Huang, Chongmei, Xu, Xiaowei, Qiu, Huiying, Niu, Jiahua, Zhou, Kun, Zhang, Ying, Xia, Xinxin, Wei, Yu, Shen, Chang, Tong, Yin, Dong, Baoxia, Wan, Liping, Song, Xianmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10639171/
https://www.ncbi.nlm.nih.gov/pubmed/37954615
http://dx.doi.org/10.3389/fimmu.2023.1252879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10639171/
https://www.ncbi.nlm.nih.gov/pubmed/37954615
http://dx.doi.org/10.3389/fimmu.2023.1252879

Ejemplares similares